{"id":"W2150701651","doi":"10.1016/s1535-6108(03)00241-1","title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","year":2003,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":848,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université du Québec à Montréal; McGill University; Terry Fox Research Institute; University of Ottawa; Ottawa Regional Cancer Foundation","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Oncolytic virus; Vesicular stomatitis virus; Innate immune system; Lytic cycle; Ovarian cancer; Biology; Cancer; Interferon; Immunity; Cancer cell; Clearance; Cancer research; Immune system; Immunology; Vesicular Stomatitis; Virology; Virus; Medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02368840543473547,"score_gpt":0.2937026590417071,"score_spread":0.2700142536069716,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}